Centre for Infectious Medicine, Department of Medicine; Clinical Genetics Unit, Department of Molecular Medicine and Surgery, and Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Minneapolis, MN 55455.
Centre for Infectious Medicine, Department of Medicine; Clinical Genetics Unit, Department of Molecular Medicine and Surgery, and Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden.
J Exp Med. 2014 Jun 2;211(6):1079-91. doi: 10.1084/jem.20131131. Epub 2014 May 19.
Autosomal recessive mutations in UNC13D, the gene that encodes Munc13-4, are associated with familial hemophagocytic lymphohistiocytosis type 3 (FHL3). Munc13-4 expression is obligatory for exocytosis of lytic granules, facilitating cytotoxicity by T cells and natural killer (NK) cells. The mechanisms regulating Munc13-4 expression are unknown. Here, we report that Munc13-4 is highly expressed in differentiated human NK cells and effector CD8(+) T lymphocytes. A UNC13D c.118-308C>T mutation, causative of FHL3, disrupted binding of the ETS family member ELF1 to a conserved intronic sequence. This mutation impairs UNC13D intron 1 recruitment of STAT4 and the chromatin remodeling complex component BRG1, diminishing active histone modifications at the locus. The intronic sequence acted as an overall enhancer of Munc13-4 expression in cytotoxic lymphocytes in addition to representing an alternative promoter encoding a novel Munc13-4 isoform. Mechanistically, T cell receptor engagement facilitated STAT4-dependent Munc13-4 expression in naive CD8(+) T lymphocytes. Collectively, our data demonstrates how chromatin remodeling within an evolutionarily conserved regulatory element in intron 1 of UNC13D regulates the induction of Munc13-4 expression in cytotoxic lymphocytes and suggests that an alternative Munc13-4 isoform is required for lymphocyte cytotoxicity. Thus, mutations associated with primary immunodeficiencies may cause disease by disrupting transcription factor binding.
常染色体隐性 UNC13D 基因突变,该基因编码 Munc13-4,与家族性噬血细胞性淋巴组织细胞增多症 3 型(FHL3)有关。Munc13-4 的表达对于溶酶体颗粒的胞吐作用是必需的,促进 T 细胞和自然杀伤(NK)细胞的细胞毒性。调节 Munc13-4 表达的机制尚不清楚。在这里,我们报告 Munc13-4 在分化的人 NK 细胞和效应 CD8(+) T 淋巴细胞中高度表达。UNC13D c.118-308C>T 突变,导致 FHL3,破坏了 ETS 家族成员 ELF1 与保守内含子序列的结合。这种突变会损害 UNC13D 内含子 1 募集 STAT4 和染色质重塑复合物成分 BRG1,减少该基因座的活性组蛋白修饰。除了代表编码新型 Munc13-4 同工型的替代启动子外,内含子序列还充当了细胞毒性淋巴细胞中 Munc13-4 表达的整体增强子。从机制上讲,T 细胞受体的参与促进了幼稚 CD8(+) T 淋巴细胞中 STAT4 依赖性 Munc13-4 表达。总之,我们的数据表明 UNC13D 内含子 1 内进化保守的调节元件内的染色质重塑如何调节细胞毒性淋巴细胞中 Munc13-4 表达的诱导,并表明替代的 Munc13-4 同工型是淋巴细胞细胞毒性所必需的。因此,与原发性免疫缺陷相关的突变可能通过破坏转录因子结合而导致疾病。